ArticleAIDS (London, England)2026
Major ECG abnormalities and risk of incident cardiovascular disease in people with HIV compared to people without HIV.
Article in AIDS (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesPeople with HIV (PWH) have an increased risk of cardiovascular disease (CVD). In the general population, major electrocardiographic (ECG) abnormalities have been associated with increased risk of incident CVD. We compared the role of major ECG abnormalities in CVD between PWH and people without HIV (PWoH).
methodsPWH and PWoH with ≥1 ECG across six biennial study visits and without prior CVD were included. Transition intensities (TI) between: no major ECG abnormality, major ECG abnormality, and CVD were estimated using a multistate Markov model. Hazard ratios (HRs) were adjusted for age and BMI. Post hoc analyses explored whether inflammatory markers influenced the association between HIV-status and transitions.
resultsOverall, 1060 participants were included (540 PWH and 520 PWoH; median age = 52 years, IQR = 48-58). During a median follow-up of 10.8 years interquartile range, (IQR = 6.8-11.0), 69 (12.8%) PWH and 52 (10.0%) PWoH had any major ECG abnormality ( P = 0.16), while 65 (12%) PWH and 41 (8%) PWoH ( P = 0.024) had an incident CVD event. There were 55 transitions from no major abnormality to major abnormality (TI = 0.76/100PY, 95% CI = 0.58-1.00) with no difference between PWH and PWoH (adjusted-HR = 1.57, 95% CI = 0.92-2.68). There were 18 transitions from major abnormality to CVD (TI = 3.38/100PY, 95% CI = 1.98-5.75), with a significantly higher TI for PWH (adjusted-HR = 3.24, 95% CI = 1.11-9.55). Adjustment for interleukin-6 attenuated the HR of HIV for this transition by 16%.
conclusionPWH with major ECG abnormalities had a significantly higher risk of incident CVD than PWoH, possibly related to systemic inflammation. Given the low probability of developing these abnormalities, routine ECG screening is unlikely to be of benefit.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.